2021 LB Jermaine Hamilton-Jordan Recaps Notre Dame Visit

April 13, 2019
2,212

Jermaine Hamilton-Jordan‍ was paying attention to everything, but the 2021 Missouri linebacker was paying extra attention to a certain Notre Dame running back during the Irish’s Blue-Gold Game on Saturday.

“I know Jafar Armstrong personally,” Hamilton-Jordan said. “He came from the city where I’m located now.”

“Every time he was on the field, I recorded it. I got his touchdown. I think he had nine carries for 85 yards and a touchdown.”

The 6-foot-1, 195-pound Hamilton-Jordan enjoyed his entire trip to South Bend.

“I really liked it,” he said. “I just liked the people and the atmosphere. Everything was great.

“I got to interact with some of the players. I was in the locker room. I sat through the prayer. I said the prayer with the guys. I ate and enjoyed the food they had. We were on the field for a couple minutes. We toured the facility and saw Touchdown Jesus.”

The Lincoln College Prep standout didn’t get a ton of one-on-one time with the coaching staff, but there should be time for the in the future.

“Since it was the spring game, all of them were pretty busy,” Hamilton-Jordan explained. “But Clark Lea, the linebackers coach, and Aaryn Kearney, the recruiting coordinator, told me that they’re going to stay in touch. I will be back up at Notre Dame June 9th for the camp.”

He’s looking forward to the opportunity to prove what he can do.

“I’ve promoted myself a lot,” he acknowledged. “I just have to keep my word. I’m going to show them I’m one of the best linebackers in the nation in the 2021 class.”

Hamilton-Jordan doesn’t have any offers yet, but is receiving interest from several schools and will be checking out some of the schools in the near future.

“Right now, I’m planning on going to LSU and Florida State and also UCLA,” he said. “The other schools I’m getting interest from are Nebraska, Iowa, Iowa State, Mizzou and Arkansas.”

 
×
Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.